EBOLA VIRUS DISEASE
Clinical trials for EBOLA VIRUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new EBOLA VIRUS DISEASE trials appear
Sign up with your email to follow new studies for EBOLA VIRUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could an antibody drug block the ebola vaccine? new study aims to find out.
Prevention Not yet recruitingThis study looks at whether giving an Ebola vaccine (Ervebo) together with an antibody drug (Inmazeb) still protects people from Ebola. The vaccine takes time to work, while the antibody acts fast, so combining them might offer better protection. About 132 healthy adults will tak…
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Prevention
Last updated May 26, 2026 11:41 UTC
-
Ebola shield: new trial tests vaccine + antibody cocktail for High-Risk contacts
Prevention Not yet recruitingThis study tests whether giving a vaccine plus an antibody drug right after high-risk Ebola exposure works better than the vaccine alone. It involves 160 people who have had close contact with an Ebola patient. The goal is to see which approach prevents more people from getting s…
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Prevention
Last updated May 18, 2026 12:03 UTC